12:00 AM
 | 
Nov 04, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Busulipo regulatory update

Pharmalink said FDA granted Orphan Drug designation for Busulipo, a liposome formulation of the generic chemotherapeutic busulfan, as...

Read the full 68 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >